Results 21 to 30 of about 25,325 (232)

TSC1/TSC2 signaling in the CNS [PDF]

open access: yesFEBS Letters, 2011
Over the past several years, the study of a hereditary tumor syndrome, tuberous sclerosis complex (TSC), has shed light on the regulation of cellular proliferation and growth. TSC is an autosomal dominant disorder that is due to inactivating mutations in TSC1 or TSC2 and characterized by benign tumors (hamartomas) involving multiple organ systems.
Han, Juliette M., Sahin, Mustafa
openaire   +2 more sources

Hypo-Expression of Tuberin Promotes Adenomyosis via the mTOR1-Autophagy Axis

open access: yesFrontiers in Cell and Developmental Biology, 2021
Adenomyosis (AM) is a disease in which endometrial tissue invades the myometrium and has a 10–60% prevalence in reproductive-aged women. TSC2 regulates autophagy via mTOR1 signalling in colorectal cancer and endometrial carcinoma.
Ni-Hao Gu   +20 more
doaj   +1 more source

Loss of myeloid Tsc2 predisposes to angiotensin II-induced aortic aneurysm formation in mice

open access: yesCell Death and Disease, 2022
Rationale Genetic studies have proved the involvement of Tuberous sclerosis complex subunit 2 (Tsc2) in aortic aneurysm. However, the exact role of macrophage Tsc2 in the vascular system remains unclear.
Xue Liu   +4 more
doaj   +1 more source

Regulation of the mammalian target of rapamycin complex 2 (mTORC2) [PDF]

open access: yes, 2006
The growth controlling mammalian Target of Rapamycin (mTOR) is a conserved Ser/Thr kinase found in two structurally and functionally distinct complexes, mTORC1 and mTORC2.
Molle, Klaus-Dieter
core   +1 more source

Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling [PDF]

open access: yes, 2009
BackgroundMammalian target of rapamycin complex 1 (mTORC1) is a protein kinase that relays nutrient availability signals to control numerous cellular functions including autophagy, a process of cellular self-eating activated by nutrient depletion ...
Trevor C F Tsang   +31 more
core   +2 more sources

Tuberous sclerosis complex: Clinical spectrum and epilepsy: A retrospective chart review study

open access: yesTranslational Neuroscience, 2018
Tuberous sclerosis complex (TSC) is an autosomal dominant genetic neurocutaneous disorder, with heterogeneous manifestations. We aimed to review the clinical presentation of TSC and its association with epilepsy among Saudi population.
Almobarak Sulaiman   +7 more
doaj   +1 more source

Tsc2 shapes olfactory bulb granule cell molecular and morphological characteristics

open access: yesFrontiers in Molecular Neuroscience, 2022
Tuberous Sclerosis Complex (TSC) is a neurodevelopmental disorder caused by mutations that inactivate TSC1 or TSC2. Hamartin and tuberin are encoded by TSC1 and TSC2 which form a GTPase activating protein heteromer that inhibits the Rheb GTPase from ...
Victoria A. Riley   +3 more
doaj   +1 more source

Identifcation of genotypescarriers of resistance to tan spot Ptr ToxA and Ptr ToxB of Pyrenophora tritici-repentis in common wheat collection

open access: yesВавиловский журнал генетики и селекции, 2019
Pyrenophora tritici-repentis (Ptr) is the causative agent of tan spot, one of the yield limiting diseases of wheat, rapidly increasing in wheat growing countries including Kazakhstan.
A. М. Kokhmetova   +3 more
doaj   +1 more source

Akt phosphorylates both Tsc1 and Tsc2 in Drosophila, but neither phosphorylation is required for normal animal growth. [PDF]

open access: yesPLoS ONE, 2009
Akt, an essential component of the insulin pathway, is a potent inducer of tissue growth. One of Akt's phosphorylation targets is Tsc2, an inhibitor of the anabolic kinase TOR. This could account for part of Akt's growth promoting activity.
Sibylle Schleich, Aurelio A Teleman
doaj   +1 more source

two variants of TSC2

open access: yes, 2021
These're the raw sequencing results of two TSC2 ...
Chenchen Zhang
core   +1 more source

Home - About - Disclaimer - Privacy